Factors	factors	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
clinical	clinical	O	O	O	O
outcome	outcome	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
amikacin	amikacin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Data	data	O	O	O	O
from	from	O	O	O	O
60	60	O	O	O	O
patients	patients	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
amikacin	amikacin	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
analyzed	analyzed	O	O	O	O
for	for	O	O	O	O
factors	factors	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
42	42	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
data	data	O	O	O	O
were	were	O	O	O	O
examined	examined	O	O	O	O
for	for	O	O	O	O
factors	factors	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
clinical	clinical	O	O	O	O
outcome	outcome	O	O	O	O
.	.	O	O	O	O

Variables	variables	O	O	O	O
evaluated	evaluated	O	O	O	O
included	included	O	O	O	O
patient	patient	O	O	O	O
weight	weight	O	O	O	O
,	,	O	O	O	O
age	age	O	O	O	O
,	,	O	O	O	O
sex	sex	O	O	O	O
,	,	O	O	O	O
serum	serum	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
,	,	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
clearance	clearance	O	O	O	O
,	,	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
,	,	O	O	O	O
total	total	O	O	O	O
dose	dose	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
daily	daily	O	O	O	O
dose	dose	O	O	O	O
,	,	O	O	O	O
organism	organism	O	O	O	O
minimum	minimum	O	O	O	O
inhibitory	inhibitory	O	O	O	O
concentration	concentration	O	O	O	O
(	(	O	O	O	O
MIC	mic	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
peak	peak	O	O	O	O
levels	levels	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
trough	trough	O	O	O	O
levels	levels	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
area	area	O	O	O	O
under	under	O	O	O	O
the	the	O	O	O	O
serum	serum	O	O	O	O
concentration-time	concentration-time	O	O	O	O
curve	curve	O	O	O	O
(	(	O	O	O	O
AUC	auc	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
total	total	O	O	O	O
AUC	auc	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
AUC	auc	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
MIC	mic	O	O	O	O
,	,	O	O	O	O
total	total	O	O	O	O
AUC	auc	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
MIC	mic	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
Schumacher	schumacher	O	O	O	O
's	's	O	O	O	O
intensity	intensity	O	O	O	O
factor	factor	O	O	O	O
(	(	O	O	O	O
IF	if	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
total	total	O	O	O	O
IF	if	O	O	O	O
,	,	O	O	O	O
In	in	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
maximum	maximum	O	O	O	O
concentration	concentration	O	O	O	O
[Cmax]/MIC	[cmax]/mic	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Model-dependent	model-dependent	O	O	O	O
pharmacokinetic	pharmacokinetic	O	O	O	O
parameters	parameters	O	O	O	O
were	were	O	O	O	O
calculated	calculated	O	O	O	O
by	by	O	O	O	O
computer	computer	O	O	O	O
based	based	O	O	O	O
on	on	O	O	O	O
a	a	O	O	O	O
one-compartment	one-compartment	O	O	O	O
model	model	O	O	O	O
.	.	O	O	O	O

When	when	O	O	O	O
the	the	O	O	O	O
parameters	parameters	O	O	O	O
were	were	O	O	O	O
examined	examined	O	O	O	O
individually	individually	O	O	O	O
,	,	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
and	and	O	O	O	O
total	total	O	O	O	O
AUC	auc	O	O	O	O
correlated	correlated	O	O	O	O
significantly	significantly	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
.05	.05	O	O	O	O
)	)	O	O	O	O
with	with	O	O	O	O
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
stepwise	stepwise	O	O	O	O
discriminant	discriminant	O	O	O	O
function	function	O	O	O	O
analysis	analysis	O	O	O	O
identified	identified	O	O	O	O
only	only	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
.001	.001	O	O	O	O
)	)	O	O	O	O
as	as	O	O	O	O
an	an	O	O	O	O
important	important	O	O	O	O
factor	factor	O	O	O	O
.	.	O	O	O	O

Based	based	O	O	O	O
on	on	O	O	O	O
this	this	O	O	O	O
model	model	O	O	O	O
and	and	O	O	O	O
on	on	O	O	O	O
Bayes	bayes	O	O	O	O
'	'	O	O	O	O
theorem	theorem	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
predictive	predictive	O	O	O	O
accuracy	accuracy	O	O	O	O
of	of	O	O	O	O
identifying	identifying	O	O	O	O
"	"	O	O	O	O
nephrotoxic	nephrotoxic	O	DISEASE	OTHERS	I
"	"	O	O	O	O
patients	patients	O	O	O	O
increased	increased	O	O	O	O
from	from	O	O	O	O
0.17	0.17	O	O	O	O
to	to	O	O	O	O
0.39	0.39	O	O	O	O
.	.	O	O	O	O

When	when	O	O	O	O
examined	examined	O	O	O	O
individually	individually	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
IF	if	O	O	O	O
,	,	O	O	O	O
MIC	mic	O	O	O	O
,	,	O	O	O	O
total	total	O	O	O	O
dose	dose	O	O	O	O
,	,	O	O	O	O
mean	mean	O	O	O	O
daily	daily	O	O	O	O
dose	dose	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
ln	ln	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
Cmax/MIC	cmax/mic	O	O	O	O
)	)	O	O	O	O
correlated	correlated	O	O	O	O
significantly	significantly	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
.05	.05	O	O	O	O
)	)	O	O	O	O
with	with	O	O	O	O
cure	cure	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
simultaneous	simultaneous	O	O	O	O
multivariable	multivariable	O	O	O	O
analysis	analysis	O	O	O	O
identified	identified	O	O	O	O
IF	if	O	O	O	O
,	,	O	O	O	O
MIC	mic	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
total	total	O	O	O	O
dose	dose	O	O	O	O
according	according	O	O	O	O
to	to	O	O	O	O
one	one	O	O	O	O
model	model	O	O	O	O
and	and	O	O	O	O
ln	ln	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
Cmax/MIC	cmax/mic	O	O	O	O
)	)	O	O	O	O
according	according	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
second	second	O	O	O	O
statistical	statistical	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
parameters	parameters	O	O	O	O
selected	selected	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
the	the	O	O	O	O
greatest	greatest	O	O	O	O
prospective	prospective	O	O	O	O
value	value	O	O	O	O
.	.	O	O	O	O

Based	based	O	O	O	O
on	on	O	O	O	O
Bayes	bayes	O	O	O	O
'	'	O	O	O	O
theorem	theorem	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
model	model	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
predictive	predictive	O	O	O	O
accuracy	accuracy	O	O	O	O
of	of	O	O	O	O
identifying	identifying	O	O	O	O
patients	patients	O	O	O	O
not	not	O	O	O	O
cured	cured	O	O	O	O
increased	increased	O	O	O	O
from	from	O	O	O	O
0.19	0.19	O	O	O	O
to	to	O	O	O	O
0.83	0.83	O	O	O	O
.	.	O	O	O	O

For	for	O	O	O	O
the	the	O	O	O	O
second	second	O	O	O	O
model	model	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
predictive	predictive	O	O	O	O
accuracy	accuracy	O	O	O	O
increased	increased	O	O	O	O
from	from	O	O	O	O
0.19	0.19	O	O	O	O
to	to	O	O	O	O
0.50.(ABSTRACT	0.50.(abstract	O	O	O	O
TRUNCATED	truncated	O	O	O	O
AT	at	O	O	O	O
250	250	O	O	O	O
WORDS	words	O	O	O	O
)	)	O	O	O	O

